On ECHEMI
Home > Drugs > Lansoprazole enteric-coated tablets

Lansoprazole enteric-coated tablets

Function and Efficacy

This product is a benzimidazole compound. After oral absorption, it is transferred to the gastric mucosa and converted into an active metabolite under acidic conditions. The activated body specifically inhibits the H/K-ATPase system of gastric parietal cells and blocks the final step of gastric acid secretion. This product inhibits basal gastric acid secretion and gastric acid secretion under stimulation in a dose-dependent manner. This product has no antagonistic effect on choline and amine H2 receptors.

Ingredients

Lansoprazole

Name Description Content CAS NO. Manufacturer
LansoprazoleIngredients

This product is a benzimidazole compound. After oral absorption, it is transferred to the gastric mucosa and converted into an active metabolite under acidic conditions. The activated body specifically inhibits the H/K-ATPase system of gastric parietal cells and blocks the final step of gastric acid secretion. This product inhibits basal gastric acid secretion and gastric acid secretion under stimulation in a dose-dependent manner. This product has no antagonistic effect on choline and amine H2 receptors.

More
103577-45-3 88

Appearance

This product is enteric-coated tablets, which appear white or light yellow-brown after removing the coating.

Indication

Gastric ulcer, duodenal ulcer, reflux esophagitis, Zollinger-Ellison syndrome (gastrinoma).

Usage and Dosage

Adults usually take lansoprazole tablets orally, once a day, two tablets (30 mg) at a time. For duodenal ulcer, take it continuously for 4-6 weeks; for gastric ulcer, reflux esophagitis, and Zollinger-Ellison syndrome, take it continuously for 6-8 weeks; or as directed by a doctor.

Adverse Reactions

1. Allergy: Occasionally there are symptoms such as rash and itching. If the above symptoms occur, please stop taking the medicine. 2. Blood system: Occasionally there are symptoms such as anemia, leukopenia, eosinophilia, etc., and symptoms of thrombocytopenia rarely occur. 3. Digestive system: Occasionally there are symptoms such as constipation, diarrhea, thirst, and abdominal distension. Occasionally there are phenomena such as ALT, AST, ALP, LDH, and γ-GTP increase, so you must observe carefully. If there are abnormal phenomena, you should take appropriate measures such as stopping the drug. 4. Mental and nervous system: Occasionally there are symptoms such as headache and drowsiness. Insomnia, dizziness and other symptoms rarely occur. 5. Others: Occasionally there are symptoms such as fever, increased total cholesterol, and increased uric acid.

Precautions

Pregnant or lactating women should not use it.

Special Population Medication

Precautions for children: The safety of the drug for children has not yet been established (there is very little clinical experience in children). Precautions for pregnancy and lactation: Pregnant and lactating women should not use. Precautions for the elderly: Generally speaking, the gastric acid secretion capacity and other physiological functions of elderly patients will be reduced, so please pay attention during medication.

Drug Interactions

Lansoprazole will delay the metabolism and excretion of diazepam and phenytoin, increase the peak blood concentration of acetaminophen, and shorten the time to reach the peak.

Storage

Keep away from light and store in sealed container.

Packaging Specification

15mg

Validity Period

24 months.

Manufacturer

Yangzhou NO.3 Pharmacitical Manufacture Co., Ltd.

  • Founded in:

    2000-12-28
  • Address:

    No. 51, Guotai Road, Yiling Town, Jiangdu District, Yangzhou City
  • Tax NO.:

    91321012717489085N
  • Registered Funds:

    7.796697 yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.